|
業務類別
|
-- |
|
業務概覽
|
Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. |
| 公司地址
| 1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004 |
| 電話號碼
| +81 352195100 |
| 傳真號碼
| +81 352195103 |
| 公司網頁
| https://www.alfresa.com |
| 員工數量
| 15500 |
| Mr. Ryuji Arakawa |
Director and President |
-- |
23/06/2026 |
| Mr. Yusuke Fukujin |
Director and Executive Vice President, Ethical Pharmaceuticals Wholesaling Business and International Business |
-- |
23/06/2026 |
| Mr. Shigeki Ohashi |
Director, Vice President and Executive Officer, Group Business Strategy |
-- |
23/06/2026 |
| Mr. Toshiki Tanaka |
Director, Vice President and Executive Officer, Corporate Administration |
-- |
23/06/2026 |
|
|
| Mr. Manabu Kinoshita |
Independent Director |
23/06/2026 |
| Mr. Ryuji Arakawa |
Director and President |
23/06/2026 |
| Mr. Koichi Shimada |
Director |
23/06/2026 |
| Mr. Yusuke Fukujin |
Director and Executive Vice President, Ethical Pharmaceuticals Wholesaling Business and International Business |
23/06/2026 |
| Ms. Toshie Takeuchi |
Independent Director |
23/06/2026 |
| Mr. Shigeki Ohashi |
Director, Vice President and Executive Officer, Group Business Strategy |
23/06/2026 |
| Mr. Toshiki Tanaka |
Director, Vice President and Executive Officer, Corporate Administration |
23/06/2026 |
| Ms. Kimiko Kunimasa |
Independent Director |
23/06/2026 |
| Ms. Sachiko Iizuka |
Independent Director |
23/06/2026 |
| Mr. Hiroshi Kizaki |
Independent Director |
23/06/2026 |
| Mr. Yuji Ueda |
Director |
23/06/2026 |
| Mr. Takashi Ito |
Independent Director |
23/06/2026 |
|
|
|
|
